Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Hypomethylating agent 5-aza-2'-deoxycytidine (DAC) ameliorates multiple sclerosis in [PMID: 24700487] Laboratory literature summary: Hypomethylating agent 5-aza-2'-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models
Not recommended for those with severe kidney disease or certain metabolic disordersconsult our medical team
Dosing and PK/PD alignment Select route and schedule that achieve sustained receptor activation within an acceptable tolerability window
The deficiency can arise due to improper diet or the inability to absorb the vitamin through natural means
US$ 21.61
US$ 25.51
US$ 26.70
US$ 25.41
US$ 28.44
US$ 26.62
US$ 27.39
